Skip to content

Management of Non-Organic Dysphonia in Adults.

Resonance Tube Voice Therapy Versus Smith Accent Therapy in The Management of Non-Organic Dysphonia in Adults

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06856785
Enrollment
60
Registered
2025-03-04
Start date
2025-03-31
Completion date
2025-09-30
Last updated
2025-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dysphonia, Resonance Tube Voice Therapy, Smith Accent Method Therapy

Brief summary

The purpose of this study is to determine the effect of a semi-occluded vocal tract training program, Resonant Tube Therapy, versus the Traditional Smith-accent Method on the quality of voice in patients with Non-Organic Functional dysphonia.

Interventions

OTHERResonance Tube Voice Therapy in Water

Resonance Tube of 28 cm in length and 9 mm diameter for adults will be submerged into a bowl of water .Both flexible soft walled tubes,glass tubes or straws can be used

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients diagnosed with non-organic functional dysphonia with or without Minimally Associated Pathological lesions and referred for voice therapy. The diagnosis was based on the results of the routine clinical assessment of cases of voice disorders by a phoniatrician in the voice clinic. * Patients 'ages between 15 - 60 years old. * Native speakers of Arabic. * Language comprehension adequate for the task.

Exclusion criteria

* Patients with organic voice disorders. * Patients with aphonia or Phon asthenia. * Females within the week of their menstrual cycle or menstruating at the time of data collection to control for the possible hormonal effects or premenstrual water retention on voice quality. * History of severe respiratory allergies, thyroid pathologies, neuro-motor impairment, hearing impairment, psychiatric problems and physically limiting diseases that might interfere with study completion. * Those on any regular medication that might affect voice quality. * Speech disorders. * Cigarette smoking, alcohol, or drug abuse for the past 5 years. * Patients with previous micro laryngeal surgery. * Patients with gastrointestinal reflux disease.

Design outcomes

Primary

MeasureTime frameDescription
Voice quality improvement in functional (non-organic) dysphonia adult patients12 weeks following end of the treatmentPatient evaluation will be conducted before and after the voice therapy sessions for the two groups by Voice Handicap Index (VHI).

Countries

Egypt

Contacts

Primary ContactShereen Hamed, Resident Physician
shereen.mohammad@med.sohag.edu.eg+201120645166

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026